Thursday, December 21, 2017 10:15 PM ET
Insider at Concert Pharmaceuticals (CNCE) Makes Significant Sale of Stock Slowing Buy Trend of Last Quarter
A SEC filing today indicated a substantial insider sale of Concert Pharmaceuticals shares as — BVF Partners Il Lp, 10% Owner — disposed of 1,282,856 shares in the company having a market value of approximately $34,188,112. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 331,916 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 950,940 shares and have averaged 807,386 shares per transaction over this time period.
In relation to the peer group over the last 90 days, insider buy/sell trading at Concert Pharmaceuticals is higher than the 190-company peer group average. Biotechnology & Medical Research peer group saw 158 buy/sell trades during this period for an average of 0.8 transactions per company. The number of shares per buy/sell trade for Concert Pharmaceuticals insiders was also higher. Within the peer group there were 26,753,926 shares purchased and 11,089,712 shares sold with company insiders purchasing 137,405 shares on average.
For the purpose of evaluating significant insider buying and selling all trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data obtained to evaluate and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.